Treatment Options for Patients With Mild-to-Moderate Coronavirus Disease 2019 in Korea

Author:

Jeon Jaehyun12ORCID,Chin BumSik3ORCID

Affiliation:

1. Research Institute for Public Healthcare, National Medical Center, Seoul, Korea.

2. Department of Infectious Diseases, Clinical Infectious Disease Research Center, National Medical Center, Seoul, Korea.

3. Division of Infectious Diseases, Department of Internal Medicine, National Medical Center, Seoul, Korea.

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Reference42 articles.

1. World Health Organization (WHO). Coronavirus (COVID-19) dashboard. Updated 2022. Accessed October 26, 2022. https://covid19.who.int/

2. Korea Disease Control and Prevention Agency. Daily and cumulative number of confirmed cases. Updated October 30, 2022. Accessed October 30, 2022. https://ncov.kdca.go.kr/en/bdBoardList.do?brdId=16&brdGubun=161&dataGubun=&ncvContSeq=&contSeq=&board_id=&gubun=

3. Korea Disease Control and Prevention Agency. The status of genomic surveillance of the COVID-19 variant virus. Updated October 20, 2022. Accessed October 29, 2022. https://kdca.go.kr/contents.es?mid=a20107030000

4. Mild or Moderate Covid-19

5. COVID-19 Therapeutics for Nonhospitalized Patients

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3